Publication Results (34)

• Cost-effectiveness of second-line ipilimumab for metastatic melanoma: a real-world population-based cohort study of resource utilization

  Lu B, Dai WF, Croxford R, Isaranuwatchai W, Beca J, Menjak IB, Petrella TM, Mittmann N, Earle CC, Gavura S, Mercer RE, Hanna TP, Chan KKW. Cancer Med. 2023; Mar 31 [Epub ahead of print]. DOI: https://doi.org/10.1002/cam4.5862

• Timeliness and modality of treatment for new cancer diagnoses during the COVID-19 pandemic in Canada

  Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Tinmouth J, Eskander A. JAMA Netw Open. 2023; 6(1):e2250394. Epub 2023 Jan 10. DOI: https://doi.org/10.1001/jamanetworkopen.2022.50394

• Quality of end-of-life care in gastrointestinal cancers: a 13-year population-based retrospective analysis in Ontario, Canada

  Lees CSR, Seow H, Chan KKW, Gayowsky A, Sinnarajah A. Curr Oncol. 2022; 29(12):9163-71. Epub 2022 Nov 24. DOI: https://doi.org/10.3390/curroncol29120717

• Primary care utilization for patients with newly diagnosed cancer during the COVID-19 pandemic: a population-based study

  Ling Y, Cheung MC, Chan KKW, Lofters A, Fox C, Patrikar A, Liu N, Singh S. BMC Cancer. 2022; 22(1):1133. Epub 2022 Nov 4. DOI: https://doi.org/10.1186/s12885-022-10257-4

• Incident cancer detection during multiple waves of COVID-19: the tsunami after the earthquake

  Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Gomez D, McIsaac DI, Enepekides D, Urbach DR, Eskander A. J Natl Compr Canc Netw. 2022; 20(11):1190-92. Epub 2022 Nov 1. DOI: https://doi.org/10.6004/jnccn.2022.7075

• Cancer patients first treated with chemotherapy: Are they more likely to receive surgery in the pandemic?

  Fu R, Sutradhar R, Dare A, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Witterick JJ, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Look Hong NJ, Eskander A. Curr Oncol. 2022; 29(10):7732-44. Epub 2022 Oct 14. DOI: https://doi.org/10.3390/curroncol29100611

• Imaging and physician visits at cancer diagnosis: COVID-19 pandemic impact on cancer care

  Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Coburn N, Hallet J, Eskander A; Pandemic-Ontario Collaborative in Cancer Research (POCCR). Cancer Med. 2022; Sep 29 [Epub ahead of print]. DOI: https://doi.org/10.1002/cam4.5321

• Trends in quality indicators of end-of-life care for women with gynecologic malignancies

  Mah SJ, Seow H, Schnarr K, Reade CJ, Gayowsky A, Chan KKW, Sinnarajah A. Gynecol Oncol. 2022; 167(2):247-55. Epub 2022 Sep 23. DOI: https://doi.org/10.1016/j.ygyno.2022.09.008

• Quality of end-of-life care in multiple myeloma: a 13-year analysis of a population-based cohort in Ontario, Canada

  Mohyuddin GR, Sinnarajah A, Gayowsky A, Chan KKW, Seow H, Mian H. Br J Haematol. 2022; 199(5):688-95. Epub 2022 Aug 10. DOI: https://doi.org/10.1111/bjh.18401

• Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy

  Climans SA, Mason WP, Grunfeld E, Chan K. J Neurooncol. 2022; 159(3):665-74. Epub 2022 Aug 6. DOI: https://doi.org/10.1007/s11060-022-04109-1

• Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy

  Climans SA, Grunfeld E, Mason WP, Chan KKW. Neuro Oncol. 2022; Mar 21 [Epub ahead of print]. DOI: https://doi.org/10.1093/neuonc/noac072

• Impact of cancer surgery slowdowns on patient survival during the COVID-19 pandemic: a microsimulation modelling study

  Parmar A, Eskander A, Sander B, Naimark D, Irish JC, Chan KKW. CMAJ. 2022; 194(11):E408-14. Epub 2022 Mar 21. DOI: https://doi.org/10.1503/cmaj.202380

• Assessing the impact of the COVID-19 pandemic on emergency department use for patients undergoing cancer-directed surgeries

  Eskander A, Li Q, Yu J, Hallet J, Coburn N, Dare A, Chan KKW, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Hanna TP, Finelli A, Louie AV, Look-Hong N, Irish JC, Witterick I, Mahar A, Urbach DR, Enepekides D, Sutradhar R; on behalf of the Pandemic—Ontario Collaborative in Cancer Research (POCCR). Curr Oncol. 2022; 29(3):1877-89. Epub 2022 Mar 10. DOI: https://doi.org/10.3390/curroncol29030153

• Comparative effectiveness and safety of pertuzumab and trastuzumab plus chemotherapy vs trastuzumab plus chemotherapy for treatment of metastatic breast cancer

  Dai WF, Beca JM, Nagamuthu C, Liu N, de Oliveira C, Earle CC, Trudeau M, Mercer RE, Chan KKW. JAMA Netw Open. 2022; 5(2):e2145460. Epub 2022 Feb 28. DOI: https://doi.org/10.1001/jamanetworkopen.2021.45460

• Cost-effectiveness analysis of pertuzumab with trastuzumab in patients with metastatic breast cancer

  Dai WF, Beca JM, Nagamuthu C, Liu N, de Oliveira C, Earle CC, Trudeau M, Chan KKW. JAMA Oncol. 2022; 8(4):597-606. Epub 2022 Feb 24. DOI: https://doi.org/10.1001/jamaoncol.2021.8049

• Incident cancer detection during the COVID-19 pandemic

  Eskander A, Li Q, Yu J, Hallet J, Coburn NG, Dare A, Chan KKW, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Hanna TP, Finelli A, Louie AV, Look Hong N, Irish JC, Witterick IJ, Mahar A, Noel CW, Urbach DR, McIsaac DI, Enepekides D, Sutradhar R. J Natl Compr Canc Netw. 2022; 20(3):276-84. Epub 2022 Feb 1. DOI: https://doi.org/10.6004/jnccn.2021.7114

• Quality of end-of-life cancer care in Canada: a 12-year retrospective analysis of three provinces’ administrative health care data evaluating changes over time

  Khan AF, Seow H, Sutradhar R, Peacock S, Chan KK, Burge F, McGrail K, Raymakers A, Lawson B, Barbera L. Curr Oncol. 2021; 28(6):4673-85. Epub 2021 Nov 12. DOI: https://doi.org/10.3390/curroncol28060394

• The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada

  Blanchette PS, Lam M, Le B, Richard L, Shariff SZ, Ouedraogo AM, Pritchard KI, Raphael J, Vandenberg T, Fernandes R, Desautels DN, Chan KKW, Earle CC. Breast. 2021; 60:295-301. Epub 2021 Oct 30. DOI: https://doi.org/10.1016/j.breast.2021.09.010

• Effect of early palliative care on end-of-life health care costs: a population-based, propensity score-matched cohort study

  Seow H, Barbera LC, McGrail K, Burge F, Guthrie DM, Lawson B, Chan KKW, Peacock SJ, Sutradhar R. JCO Oncol Pract. 2022; 18(1):e183-92. Epub 2021 Aug 13. DOI: https://doi.org/10.1200/OP.21.00299

• End-of-life outcomes with or without early palliative care: a propensity score matched, population-based cancer cohort study

  Seow H, Sutradhar R, Burge F, McGrail K, Guthrie DM, Lawson B, Oz UE, Chan K, Peacock S, Barbera L. BMJ Open. 2021; 11(2):e041432. Epub 2021 Feb 12. DOI: https://doi.org/10.1136/bmjopen-2020-041432

• Patient reported symptom burden as a predictor of emergency department use and unplanned hospitalization in head and neck cancer: a longitudinal population based study

  Noel C, Sutradhar R, Zhao H, Delibasic V, Forner D, Irish JC, Kim J, Husain Z, Mahar A, Karam I, Enepekides DJ, Chan KKW, Singh S, Hallet J, Coburn NG, Eskander A. J Clin Oncol. 2021; 39(6):675-84. Epub 2021 Jan 6. DOI: https://doi.org/10.1200/JCO.20.01845

• Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada

  Dai WF, Beca J, Croxford R, Isaranuwatchai W, Menjak IB, Petrella TM, Mittmann N, Earle CC, Gavura S, Mercer RE, Hanna TP, Chan KKW. Int J Cancer. 2021; 148(8):1910-8. Epub 2020 Oct 26. DOI: https://doi.org/10.1002/ijc.33357

• Patterns of care and costs for older patients with colorectal cancer at the end of life: descriptive study of the United States and Canada

  Bremner KE, Yabroff KR, Coughlan D, Liu N, Zeruto C, Warren JL, de Oliveira C, Mariotto AB, Lam C, Barrett MJ, Chan KK, Hoch JS, Krahn MD. JCO Oncol Pract. 2020; 16(1):e1-18. Epub 2019 Oct 24. DOI: 10.1200/JOP.19.00061.

• Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study

  Thein HH, Jembere N, Thavorn K, Chan KKW, Coyte PC, de Oliveira C, Hur C, Earle CC. BMC Cancer. 2018; 18(1):694. Epub 2018 Jun 27.

• The economic burden of cancer care in Canada: a population-based cost study

  de Oliveira C, Weir S, Rangrej J, Krahn MD, Mittmann N, Hoch JS, Chan KKW, Peacock S. CMAJ Open. 2018; 6(1):E1-10. Epub 2018 Jan 4.

• Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013

  Gong IY, Yan AT, Ko DT, Earle CC, Cheung WY, Peacock S, Hall M, Gale CP, Chan KKW. Cancer. 2018; 124(6):1269-78. Epub 2017 Dec 6.

• Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting

  Thein HH, Qiao Y, Zaheen A, Jembere N, Sapisochin G, Chan KKW, Yoshida EM, Earle CC. PLoS One. 2017; 12(10):e0185198.

• Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian setting

  Thein HH, Isaranuwatchai W, Qiao Y, Wong K, Sapisochin G, Chan KKW, Yoshida EM, Earle CC. Cancer Med. 2017; 6(9):2017-33. Epub 2017 Aug 8.

• Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study

  Yan AT, Koh M, Chan KK, Guo H, Alter DA, Austin PC, Tu JV, Wijeysundera HC, Ko DT. J Am Coll Cardiol. 2017; 69(12):1523-32.

• Estimating the cost of cancer care in British Columbia and Ontario: a Canadian inter-provincial comparison

  de Oliveira C, Pataky R, Bremner KE, Rangrej J, Chan KKW, Cheung WY, Hoch JS, Peacock S, Krahn MD. Healthc Policy. 2017; 12(3):95-108.

• Phase-specific and lifetime costs of cancer care in Ontario, Canada

  de Oliveira C, Pataky R, Bremner KE, Rangrej J, Chan KK, Cheung WY, Hoch JS, Peacock S, Krahn MD. BMC Cancer. 2016; 16:809. Epub 2016 Oct 18.

• Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study

  Gong IY, Verma S, Yan AT, Ko DT, Earle CC, Tomlinson GA, Trudeau ME, Krahn MD, Krzyzanowska MK, Brezden-Masley CB, Gavura S, Peacock S, Chan KK. Breast Cancer Res Treat. 2016; 157(3):535-44. Epub 2016 Jun 6.

• The temporal risk of heart failure associated with adjuvant trastuzumab in breast cancer patients: a population study

  Goldhar HA, Yan AT, Ko DT, Earle CC, Tomlinson GA, Trudeau ME, Krahn MD, Krzyzanowska MK, Pal RS, Brezden-Masley C, Gavura S, Lien K, Chan KK. J Natl Cancer Inst. 2016; 108(1):djv301. Epub 2015 Oct 16.

• Early survival for patients newly diagnosed with cancer during COVID-19 in Ontario, Canada: a population-based cohort study

  Fu R, Sutradhar R, Li Q, Kalraj P, Dare A, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Louie AV, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Gomez D, Look Hong NJ, Tinmouth J, Eskander A. Cancer Med. 2023; Mar 31 [Epub ahead of print]. DOI: https://doi.org/10.1002/cam4.5861